Clinical Trial Update: Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness of Onabotulinumtoxin A (Botox) in pediatric patients with migraines has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache Migraine
• Migraine Disorders
• Pediatrics

Drugs mentioned

• Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: University of California, Irvine | Conditions: Migraine Disorders, Headache, Migraine | Phase 2 | Status: COMPLETED | Results posted: 2023-10-18